PURPOSE
Biospecimen-based research offers tremendous promise as a way to increase understanding of the molecular epidemiology of cancers. Population-based cancer registries can augment this research by providing more clinical detail and long-term follow-up information than is typically available from biospecimen annotations. In order to demonstrate the feasibility of this concept, we performed a pilot linkage between the California Cancer Registry (CCR) and the University of California, Davis Cancer Center Biorepository (UCD CCB) databases to determine if we could identify patients with records in both databases.
METHODS
We performed a probabilistic data linkage between 2180 UCD CCB biospecimen records collected during the years 2005-2009 and all CCR records for cancers diagnosed from 1988-2009 based on standard data linkage procedures.
RESULTS
The 1040 UCD records with a unique medical record number, tissue site, and pathology date were linked to 3.3 million CCR records. Of these, 844 (81.2%) were identified in both databases. Overall, record matches were highest (100%) for cancers of the cervix and testis/other male genital system organs. For the most common cancers, matches were highest for cancers of the lung and respiratory system (93%), breast (91.7%), and colon and rectum (89.5%), and lower for prostate (72.9%).
CONCLUSIONS
This pilot linkage demonstrated that information on existing biospecimens from a cancer center biorepository can be linked successfully to cancer registry data. Linkages between existing biorepositories and cancer registries can foster productive collaborations and provide a foundation for virtual biorepository networks to support population-based biospecimen research.
[1]
M. García-Closas,et al.
Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
,
2010,
Cancer Epidemiology, Biomarkers & Prevention.
[2]
F. Bray,et al.
Ensuring quality in studies linking cancer registries and biobanks
,
2010,
Acta oncologica.
[3]
W. Anderson.
Cancer Surveillance Research
,
2009,
Cancer Epidemiology Biomarkers & Prevention.
[4]
Ashokkumar A. Patel,et al.
A multidisciplinary approach to honest broker services for tissue banks and clinical data
,
2008,
Cancer.
[5]
Pär Stattin,et al.
Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers
,
2007,
Acta oncologica.
[6]
C. Moskaluk,et al.
Tissues from population-based cancer registries: a novel approach to increasing research potential.
,
2005,
Human pathology.
[7]
C. Lynch,et al.
Procurement of population-based cancer tissue in Iowa.
,
1999,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8]
P. Boffetta.
Biomarkers in cancer epidemiology: an integrative approach.
,
2010,
Carcinogenesis.